Of the 8 sample sets from the 31 patients which revealed discordant p16/CDKN2A copy number, loss of p16/CDKN2A was observed in the relapse event and not in the primary tumour in 5 cases (3 of which also harboured IDH1 mutation). Here, IDH1 is linked to neoplasm.